There are 304 resources available
Integrated multi omic correlation with clinical response in I-O
Presenter: Michele Ceccarelli
Session: Improved immune monitoring for better drug development in I-O
Resources:
Slides
Webcast
Where I-O makes sense in urothelial carcinoma
Presenter: Thomas Powles
Session: Genitourinary tumours
Resources:
Slides
Webcast
Anti-CD30 bispecific (Fc engager) programme
Presenter: Yago Nieto
Session: Co-formulation bispecific approaches
Resources:
Slides
Webcast
Teclistamab as a challenge to CAR T
Presenter: Tobias Kampfenkel
Session: Co-formulation bispecific approaches
Resources:
Slides
Webcast
A deep dive into transcriptomics of immune cells thanks to single cell RNAseq
Presenter: Eliane Piaggio
Session: Improved immune monitoring for better drug development in I-O
Resources:
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Improved immune monitoring for better drug development in I-O
Resources:
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Genitourinary tumours
Resources:
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Co-formulation bispecific approaches
Resources:
Webcast
Introduction and first vote
Presenter: Aurelien Marabelle
Session: Is TMB a good predictive biomarker for immunotherapy?
Resources:
Slides
Webcast
119O - Long-term efficacy and patterns of response of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in patients with advanced melanoma: A 4-year analysis of the C-144-01 study
Presenter: Martin Wermke
Session: Proffered Paper session 2
Resources:
Abstract
Slides
Webcast